CIP2A regulates cell proliferation via the AKT signaling pathway in human lung cancer

Oncology Reports

Volumn 32, Issue 4, 2014, Pages 1689-1694

  Lei, Ningjing ^a   Peng, Bo ^a   Zhang, Jian Ying ^a  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

AKT signaling pathway; Cell proliferation; CIP2A; Lung cancer

Indexed keywords

CIP2A PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN KINASE B; UNCLASSIFIED DRUG; AUTOANTIGEN; KIAA1524 PROTEIN, HUMAN; MEMBRANE PROTEIN; MTOR PROTEIN, HUMAN; SMALL INTERFERING RNA; TARGET OF RAPAMYCIN KINASE;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LUNG CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; GENE SILENCING; GENETICS; LUNG TUMOR; METABOLISM; TUMOR CELL LINE;

AUTOANTIGENS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MEMBRANE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84919397185     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3375     Document Type: Article

References (22)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63: 11-30, 2013.
2. Travis WD, Travis LB and Devesa SS: Lung cancer. Cancer 75 (Suppl 1): 191-202, 1995.
3. Fong KM, Sekido Y, Gazdar AF and Minna JD: Lung cancer. 9: Molecular biology of lung cancer: clinical implications. Thorax 58: 892-900, 2003. (Pubitemid 37239240)
4. Aviel-Ronen S, Blackhall FH, Shepherd FA and Tsao MS: K-ras mutations in non-small-cell lung carcinoma: a review. Clin Lung Cancer 8: 30-38, 2006. (Pubitemid 44336241)
5. Haura EB, Camidge DR, Reckamp K, et al: Molecular origins of lung cancer: prospects for personalized prevention and therapy. J Thorac Oncol 5 (Suppl 3): S207-S213, 2010.
6. Huff V: Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer 11: 111-121, 2011.
7. Shackelford DB and Shaw RJ: The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9: 563-575, 2009.
8. Soo Hoo L, Zhang JY and Chan EK: Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer. Oncogene 21: 5006-5015, 2002.
9. Junttila MR, Puustinen P, Niemelä M, et al: CIP2A inhibits PP2A in human malignancies. Cell 130: 51-62, 2007. (Pubitemid 47039258)
10. Khanna A, Pimanda JE and Westermarck J: Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target. Cancer Res 73: 6548-6553, 2013.
11. Boehm JS, Hession MT, Bulmer SE and Hahn WC: Transformation of human and murine fibroblasts without viral oncoproteins. Mol Cell Biol 25: 6464-6474, 2005. (Pubitemid 41023222)
12. INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. Cancer Cell 4: 301-310, 2003.
13. Westermarck J and Hahn WC: Multiple pathways regulated by the tumor suppressor PP2A in transformation. Trends Mol Med 14: 152-160, 2008.
14. Côme C, Laine A, Chanrion M, et al: CIP2A is associated with human breast cancer aggressivity. Clin Cancer Res 15: 5092?5100, 2009.
15. Dong QZ, Wang Y, Dong XJ, et al: CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis. Ann Surg Oncol 18: 857-865, 2011.
16. Huang LP, Adelson ME, Mordechai E and Trama JP: CIP2A expression is elevated in cervical cancer. Cancer Biomark 8: 309-317, 2010.
17. Vaarala MH, Väisänen MR and Ristimäki A: CIP2A expression is increased in prostate cancer. J Exp Clin Cancer Res 29: 136, 2010.
18. Chen KF, Liu CY, Lin YC, et al: CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells. Oncogene 29: 6257-6266, 2010.
19. Beckebaum S, Iacob S, Klein CG, et al: Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients. Transplantation 89: 983-993, 2010.
20. Ren XS, Sato Y, Harada K, et al: Activation of the PI3K/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat. PLoS One 9: e87660, 2014.
21. Alayev A and Holz MK: mTOR signaling for biological control and cancer. J Cell Physiol 228: 1658-1664, 2013.
22. Kim DH, Sarbassov DD, Ali SM, et al: mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110: 163-175, 2002. (Pubitemid 34876545)